What Are the Proposed Changes to Medicare in 2026?
Prescription Drug Updates (Part D)
Significant Medicare 2026 changes are centered around prescription drug costs, benefitting millions of seniors enrolled in Medicare Part D. Thanks to the continued rollout of the Inflation Reduction Act (IRA), Medicare drug prices 2026 will be notably lower for select high-cost medications. These changes are particularly impactful for individuals with chronic conditions such as cancer, diabetes, heart disease, and autoimmune diseases.
- Negotiated price reductions: Starting January 1, 2026, Medicare enrollees will see lower costs for 10 blockbuster drugs. All Part D plans must include these in their formularies, with improved access for 9 of the 10 medications compared to 2025. Early estimates show beneficiaries will save approximately $1.5 billion in combined out-of-pocket expenses in the first year alone.
- Out-of-pocket cap increases: The Part D out-of-pocket cap will climb slightly to $2,100 for 2026 (up from $2,000 in 2025). Once enrollees hit this threshold, their Part D plan covers 100% of any further covered drug costs for the year, offering significant relief to those with high medication needs. For details on how Part D evolved, check When Did Medicare Part D Begin? Coverage and Updates.
- Fewer plan options: The number of standalone prescription drug plans (PDPs) shrinks by 22% (just 360 nationwide, down from 464 in 2025). Still, consumers will have 8-12 PDPs per state to choose from, making plan comparison during enrollment critical.
- Maximum deductible capped: Your Part D deductible is limited to $615 in 2026, containing annual upfront costs.
- Insulin savings continue: Many beneficiaries rely on the $35 monthly insulin cap for each 30-day supply, maintaining predictable and manageable expenses for diabetes medication.
- Monthly payment plan: The Medicare Prescription Payment Plan allows beneficiaries to pay Part D costs in monthly installments (with auto-reenrollment), easing budget strains, especially for those on multiple prescriptions.
- Weight-loss drugs and GLP-1 medications: Midyear 2026, price cuts will affect certain GLP-1s like Wegovy for qualifying conditions. However, comprehensive weight-loss drugs Medicare coverage will not likely be available until 2027. For those with Type 2 diabetes, GLP-1 Medicare coverage may apply earlier for drugs like Ozempic, but coverage is condition-specific. For the latest on these topics, beneficiaries should review plan documents during open enrollment and consult their provider.
2025 vs. 2026 Part D Comparison Table
| Feature | 2025 | 2026 |
|---|---|---|
| Out-of-pocket cap | $2,000 | $2,100 |
| Max deductible | $590 | $615 |
| Insulin copay | $35/30 days | $35/30 days |
| Negotiated drug prices | Not available | 10 high-cost drugs included |
| PDPs nationwide | 464 | 360 |
This evolving landscape means beneficiaries must carefully review their Annual Notice of Change (ANOC) and use comparison tools during open enrollment to ensure adequate and cost-effective coverage for 2026.
Premiums and Deductibles
Despite progress in drug price relief, core Medicare costs are on the rise in 2026, with new records for Part B premium 2026 and deductibles. Here’s what enrollees need to know:
- Part B Premium: The standard monthly Part B premium increases from $185 in 2025 to $202.90 in 2026-a nearly 10% hike. This bump, spurred by rising program costs and expanded benefits, will affect nearly all who use outpatient and physician services under Medicare.
- Part A Premiums: For those who do not qualify for premium-free Part A, rates go up to $311 for individuals with 30 or more quarters of coverage (up $26 from 2025) and $565 for those with fewer quarters (up $47).
- Deductibles rising: While official numbers for 2026 deductibles have not yet been released, both Part A and Part B are expected to increase. Past trends and early CMS guidance suggest above-inflation adjustments-potentially affecting affordability of hospital and physician care.
It’s crucial to reassess what level of protection you need. For those considering extra coverage, What Medicare Supplemental Insurance Do I Need in 2026? offers detailed guidance on Medigap and supplemental plan strategies.
2025 vs. 2026 Premium & Deductible Comparison
| Cost Area | 2025 | 2026 (Estimated) |
|---|---|---|
| Part B premium | $185 | $202.90 |
| Part A (30+ quarters) | $285 | $311 |
| Part A (<30 quarters) | $518 | $565 |
| Part D out-of-pocket cap | $2,000 | $2,100 |
These increases underscore the importance of budgeting for Medicare costs and exploring all coverage options, especially as the landscape changes for high-need and low-income beneficiaries.
Medicare Advantage (MA) and Plan Finder Improvements
The world of Medicare Advantage 2026 features regulatory upgrades, greater consumer protections, and a streamlined shopping process for plan selection.
- Plan Finder error fix: If you enroll in a Medicare Advantage plan based on outdated provider directory information and later discover inaccuracies, you’ll have an expanded opportunity to switch plans. This is a direct response to ongoing complaints about accuracy in the CMS Plan Finder tool.
- D-SNPs modernization: New eligibility rules shape Dual-Eligible Special Needs Plans (D-SNPs), which serve those enrolled in both Medicare and Medicaid. Starting in 2026, over-the-counter (OTC) cards for food and utilities are limited to enrollees with specified chronic conditions, like diabetes or heart failure. By 2027, D-SNPs must issue uniform ID cards and include more standardized health assessments, but initial steps begin in 2026. To better understand qualifying for these specialized plans, see Who Qualifies for Medicare Special Needs Plans?.
- Prior authorization pilots: Some 2026 MA pilots related to prior authorization (a plan’s approval process for procedures or drugs) have ended or been curtailed. However, original Medicare will test prior authorization for certain Part B services in 6 states, aiming to balance fraud prevention with efficiency and timely care.
- Fewer PDPs to choose from: The overall reduction in prescription drug plans means many enrollees will find a different mix of choices in 2026. Updated Plan Finder tools-enhanced for better usability and more accurate information-can help you compare costs, coverage, and networks efficiently during the annual enrollment window.
The Medicare Advantage plan finder updates play a crucial role for beneficiaries who want to verify provider networks, drug coverage, and costs quickly and accurately. Annual Enrollment (October 15 to December 7, 2025) remains the key opportunity to choose or switch plans for 2026.
Physician Fee Schedule and Payment Reforms
With ongoing policy evolution, the 2026 physician fee schedule and payment reforms emphasize transparency, fraud reduction, and site neutrality in care reimbursement. Here’s what stands out:
- Prior authorization experiments: A major 6-state pilot starts January 1, 2026, requiring prior authorization for select original Medicare Part B items and services. This approach will be closely watched for its impact on care delays and administrative burdens.
- Site-neutral payments: Although not fully implemented in 2026, CMS is considering broadening site-neutral payments-aligning compensation so that the same outpatient services are reimbursed at similar rates, whether delivered in hospital outpatient departments or independent clinics. This would counter payment disparities and reduce incentives for hospital acquisition of smaller practices.
- Limited fee schedule updates: No comprehensive new physician fee schedule has been released for 2026 as of June 2024. Future updates may address the conversion factor, MEI productivity adjustment, and use of the KX modifier for therapy caps-all key technical terms affecting physician reimbursement.
- Regulatory relief for providers: As the administrative burden grows, some physicians may weigh practice changes or even opt out of Medicare to avoid compliance demands (see How to Opt Out of Medicare as a Physician for provider perspectives).
These reforms may ultimately support cost containment and ensure Medicare’s sustainability, but they carry potential implications for provider access and beneficiary choice-especially for rural and specialty care.
Broader Reforms and Proposals
As part of ongoing CMS Medicare reforms 2026, several policy proposals and changes will alter both access and affordability:
- Enhancements from the IRA: Expansion of drug negotiations improves coverage for the most expensive medications under Part D, accelerating relief for millions.
- End of low-income rolling SEP: The special enrollment period (SEP) for those under 150% of the federal poverty line will be discontinued. From 2026, SEPs will be mostly limited to qualifying life events (e.g., relocation, loss of coverage, or other major changes).
- Cash-pay and private alternatives: Rising premiums may prompt a shift towards cash-pay care or supplemental private insurance among wealthier beneficiaries or those dissatisfied with traditional Medicare options.
- Ongoing regulatory fine-tuning: CMS continues to adjust rules to streamline prior authorization, reduce fraud (especially via monitoring 340B drug pricing abuse), and improve consumer transparency.
Changes also include broader access to wellness and prevention. For more, see What Is Medicare Wellness Exam? Coverage, Eligibility & Differences for the latest on preventive service eligibility.
How These Changes Impact You
With the mix of cost savings and increases, the impact of Medicare 2026 changes will vary across the 65+ population. Here’s how different groups are affected-and how you can make the most of the new rules.
- Savers: If you use one of the 10 newly negotiated high-cost drugs, or regularly reach the Part D $2,100 out-of-pocket cap, you could save hundreds to thousands of dollars in 2026, especially if you have chronic or complex health needs. It’s estimated nearly 9 million could see direct drug savings.
- Those facing higher costs: The near 10% hike in Part B premiums and rising deductibles offset some prescription drug relief. Review your Annual Notice of Change (ANOC) and matched drug list every fall for copay and cost-share changes.
- Plan shoppers: With fewer prescription drug plans but upgraded comparison tools (including ZIP-code specific options), it’s never been more important to use the updated Plan Finder and assess which plan works for your specific medications and providers.
- Dual eligibles and chronic conditions: D-SNP/OTC card eligibility has narrowed, so verify your qualification and chronic condition documentation to avoid gaps in valuable extra benefits. See expert guidance at Who Qualifies for Medicare Special Needs Plans?.
- Self-advocates and caregivers: Stay alert to changes, use official CMS sources, and be proactive during the October 15-December 7, 2025 Annual Enrollment Period for 2026 coverage. Personalized calculators (offered by major Part D and Medigap providers) can help you estimate your out-of-pocket drug costs given the new caps and potential drug price negotiations.
- Enrollment checklist for 2026:
- Review your Annual Notice of Change (ANOC) as soon as it arrives.
- List all your medications, providers, and pharmacies for comparison shopping.
- Use the Medicare Plan Finder and ZIP-specific tools for the most accurate data.
- Consult experts or plan brokers, especially for D-SNPs or chronic conditions.
- Check supplemental insurance options, especially if anticipating higher hospital or outpatient costs.
- Ask your physician’s office about prior authorization and plan participation for 2026.
By staying informed and reviewing your plan options early, you can benefit from cost savings, minimize risk from premium hikes, and confidently navigate the new landscape of Medicare in 2026.
